BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30508418)

  • 1. Protein-energy wasting and asymmetric dimethylarginine in peritoneal dialysis patients.
    Małgorzewicz S; Heleniak Z; Lichodziejewska-Niemierko M; Rutkowski R; Aleksandrowicz-Wrona E; Dębska-Ślizień A
    Acta Biochim Pol; 2018 Dec; 65(4):581-584. PubMed ID: 30508418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adipokines, endothelial dysfunction and nutritional status in peritoneal dialysis patients.
    Małgorzewicz S; Lichodziejewska-Niemierko M; Aleksandrowicz-Wrona E; Świetlik D; Rutkowski B; Łysiak-Szydłowska W
    Scand J Urol Nephrol; 2010 Dec; 44(6):445-51. PubMed ID: 20624111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of adiponectin and leptin levels with protein-energy wasting, in end stage renal disease patients.
    Markaki A; Grammatikopoulou MG; Venihaki M; Kyriazis J; Perakis K; Stylianou K
    Endocrinol Nutr; 2016 Nov; 63(9):449-457. PubMed ID: 27638461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of thyroxine replacement on the levels of serum asymmetric dimethylarginine (ADMA) and other biochemical cardiovascular risk markers in patients with subclinical hypothyroidism.
    Ozcan O; Cakir E; Yaman H; Akgul EO; Erturk K; Beyhan Z; Bilgi C; Erbil MK
    Clin Endocrinol (Oxf); 2005 Aug; 63(2):203-6. PubMed ID: 16060915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of Adiponectin, Leptin Levels, and the Change of Body Composition in Patients on Peritoneal Dialysis: A Prospective Cohort Study.
    Xu X; Tian X; Chen Y; Yang ZK; Qu Z; Dong J
    Perit Dial Int; 2018; 38(4):278-285. PubMed ID: 29674409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of renal replacement therapy on plasma, asymmetric dimethylarginine, nitric oxide and C-reactive protein levels.
    Uzun H; Konukoglu D; Besler M; Erdenen F; Sezgin C; Muderrisoglu C
    Clin Invest Med; 2008; 31(1):E1-7. PubMed ID: 18312743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiovascular morbidity and mortality risk factors in peritoneal dialysis patients].
    Jovanović DB
    Srp Arh Celok Lek; 2008; 136(5-6):313-8. PubMed ID: 18792634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperleptinaemia and chronic inflammation after peritonitis predicts poor nutritional status and mortality in patients on peritoneal dialysis.
    Lam MF; Leung JC; Lo WK; Tam S; Chong MC; Lui SL; Tse KC; Chan TM; Lai KN
    Nephrol Dial Transplant; 2007 May; 22(5):1445-50. PubMed ID: 17277343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Body composition in patients on haemodialysis: relationship between the type of haemodialysis and inflammatory and nutritional parameters.
    Gallar-Ruiz P; Digioia C; Lacalle C; Rodríguez-Villareal I; Laso-Laso N; Hinostroza-Yanahuaya J; Oliet-Pala A; Herrero-Berron JC; Ortega-Marcos O; Ortiz-Libreros M; Mon-Mon C; Cobo-Jaramillo G; Vigil-Medina A
    Nefrologia; 2012 Jul; 32(4):467-76. PubMed ID: 22806281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum asymmetric dimethylarginine and nitric oxide levels in obese postmenopausal women.
    Kocak H; Oner-Iyidogan Y; Gurdol F; Oner P; Esin D
    J Clin Lab Anal; 2011; 25(3):174-8. PubMed ID: 21567464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum leptin, resistin, and lipid levels in patients with end stage renal failure with regard to dialysis modality.
    Taskapan MC; Taskapan H; Sahin I; Keskin L; Atmaca H; Ozyalin F
    Ren Fail; 2007; 29(2):147-54. PubMed ID: 17365928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship among asymmetric dimethylarginine (ADMA) levels, residual renal function, and left ventricular hypertrophy in continuous ambulatory peritoneal dialysis patients.
    Ebinç FA; Erten Y; Ebinç H; Paşaoğlu H; Demirtaş C; Taçoy G; Mutluay R; Koç E; Derici U; Reis KA; Bali M; Arinsoy T; Sindel S
    Ren Fail; 2008; 30(4):401-6. PubMed ID: 18569913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum concentrations of leptin, adiponectin and resistin, and their relationship with cardiovascular disease in patients with end-stage renal disease.
    Díez JJ; Iglesias P; Fernández-Reyes MJ; Aguilera A; Bajo MA; Alvarez-Fidalgo P; Codoceo R; Selgas R
    Clin Endocrinol (Oxf); 2005 Feb; 62(2):242-9. PubMed ID: 15670203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gelsolin and adipokines are associated with protein-energy wasting in hemodialysis patients.
    Chiu TT; Liao SC; Lee WC; Lee PS; Ng HY; Chien YS; Lee CT
    Artif Organs; 2015 Feb; 39(2):150-5. PubMed ID: 25039281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adiponectin, leptin, nitric oxide, and C-reactive protein levels in kidney transplant recipients: comparison with the hemodialysis and chronic renal failure.
    Ocak N; Dirican M; Ersoy A; Sarandol E
    Ren Fail; 2016 Nov; 38(10):1639-1646. PubMed ID: 27764985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there any interaction of resistin and adiponectin levels with protein-energy wasting among patients with chronic kidney disease.
    Kaynar K; Kural BV; Ulusoy S; Cansiz M; Akcan B; Misir N; Yaman S; Kaya N
    Hemodial Int; 2014 Jan; 18(1):153-62. PubMed ID: 23919731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Asymmetric and Symmetric Dimethylarginine and Morbidity and Mortality in Hemodialysis Patients.
    Shafi T; Hostetter TH; Meyer TW; Hwang S; Hai X; Melamed ML; Banerjee T; Coresh J; Powe NR
    Am J Kidney Dis; 2017 Jul; 70(1):48-58. PubMed ID: 28089476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscle and fat metabolism in obesity after kidney transplantation: no effect of peritoneal dialysis or hemodialysis.
    Teplan V; Malý J; Gürlich R; Teplan V; Kudla M; Pit'ha J; Racek J; Haluzík M; Senolt L; Stollová M
    J Ren Nutr; 2012 Jan; 22(1):166-70. PubMed ID: 22200436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein-energy wasting modifies the association of ghrelin with inflammation, leptin, and mortality in hemodialysis patients.
    Carrero JJ; Nakashima A; Qureshi AR; Lindholm B; Heimbürger O; Bárány P; Stenvinkel P
    Kidney Int; 2011 Apr; 79(7):749-56. PubMed ID: 21178976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term use of vitamin E-coated polysulfone membrane reduces oxidative stress markers in haemodialysis patients.
    Morimoto H; Nakao K; Fukuoka K; Sarai A; Yano A; Kihara T; Fukuda S; Wada J; Makino H
    Nephrol Dial Transplant; 2005 Dec; 20(12):2775-82. PubMed ID: 16221689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.